| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | 1.8 | 4.3 | 4.8 |
| Total income | 592.0 | 606.0 | 569.0 |
| Net profit | -64.1 | -44.2 | -54.5 |
| Operating margin | -12.5% | -7.7% | -11.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: SAGCEM. Figures extracted from the filing.
Sagar Cements Ltd: key numbers
- Share price
- ₹148.01
- Market cap
- ₹1,935 Cr
- Revenue (annual)
- ₹2,650 Cr
- Net profit (annual)
- ₹-11.07 Cr
- P/E (TTM)
- -54.6×Sector 31.9×
- Promoter holding
- 48.33%+0.00% QoQ
- FII holding
- 1.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sagar Cements Ltd
All →Sagar Cements Earnings Call Transcript: Key Takeaways
Management maintains a confident stance on 13% volume growth despite input cost headwinds. While Q1 saw seasonal and election-related labor disruptions, commissioning of new capacity and waste heat recovery systems are expected to drive H2 margins.
Sagar Cements Investor Presentation: Key Takeaways
Sagar Cements reported Q1 FY27 revenue of ₹706 Cr (up 5% YoY) but a PAT loss of ₹28.1 Cr. Sales volume grew 13% YoY to 1.61 MnT.
Sagar Cements Q1 FY27 Results: Net Loss of ₹28.1 Cr
Sagar Cements Ltd reported revenue from operations of ₹706.1 Cr (+5.3% YoY) and a net loss of ₹28.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹28.1 Cr
Sagar Cements Board Meeting Date
Sagar Cements scheduled a Board Meeting for July 27, 2026. The board will consider un-audited standalone and consolidated financial results for the quarter ended June 30, 2026.
Sagar Cements Credit Rating
Sagar Cements' bank loan facilities were downgraded to 'IND BBB' by India Ratings. This is a regulatory disclosure of a credit rating action for investor information.
Sagar Cements Annual General Meeting
Sagar Cements held its 45th AGM via video conference. Shareholders approved financial statements and director re-appointments.